Wednesday, Aug 12 2020 | Time 17:56 Hrs(IST)
  • Youth needs to take inspiration from Netaji’s life & strive towards building a New India: Naidu
  • COVID 19 tally crosses 90 K in Bihar
  • Sheela gives birth to three cubs in Bengal Safari Park; Two half-adult elephants found dead in Buxa Tiger Forest in North Bengal
  • Capt Amarinder launches Rs 92 cr 'Punjab Smart connect schemes
  • Governor convenient punching bag in political crossfire:Dhankhar
  • COVID-19: Bangladesh registers 42 more fatalities in last 24 hours
  • COVID-19: Aurangabad reports three fatalities, 123 new cases in one-day
  • RR fielding coach Dishant Yagnik tests positive for COVID-19
  • RR fielding coach Dishant Yagnik tests positive for COVID-19
  • Doctors lethargic in treating COVID-19 suspects will be booked: KDMC
  • DAK skeptical of Russian Covid-19 vaccine
  • UP records 4583 fresh Covid cases, active cases near 50K
  • Ex-Pondy Minister dies of COVID-19
  • A thorough investigation plays pivotal role in delivering justice: Shah
  • Students move SC seeking intervention in CBSE class 10, 12 compartment tests
Business Economy

Antiviral agents effective therapeutic option for treating Covid-19, claims report

Mumbai, Jul 9 (UNI) As many as 73 per cent doctors cited ‘antiviral agents’ as the most effective therapy for treating Covid-19 while using ‘anti-inflammatory’ drugs to treat patients was found to be the second best alternative by around 13 per cent of the medicos, according to a report here.
This was followed by ‘convalescent plasma’ therapy, across the surveyed countries. The only exception was Italy, where physicians found ‘convalescent plasma’ therapy more promising than any other treatment, according to a research report that provides unique insights and perspectives on the diagnostics and treatment of COVID-19, released by Course5 Intelligence, a leading analytics and AI solutions provider headquartered in India.
The COVID-19 Report encapsulates feedback collected through focussed interviews with 30 leading physicians and infectious disease specialists across six countries -- the US, Germany, France, Italy, Spain and the UK to understand key challenges in the diagnosis and treatment of the disease.
While surveying the challenges faced by physicians in diagnosing COVID-19 patients, 63 per cent doctors were of the view that ‘sensitivity and specificity issues with testing kits’ is the biggest challenge in diagnosis, followed by ‘restrictive criteria on who should be tested’ which received 60 per cent votes.
‘Shortage of testing kits’ and ‘turnaround time for processing’ were viewed as the next biggest challenges.
On the other hand, 80 per cent physicians cited ‘ineffective therapies’ as the principal challenge in treating COVID-19 patients.
‘Large affected population’ and ‘insufficient or late diagnosis’ were the second and third biggest challenges and received 70 per cent and 50 per cent votes respectively.
Interestingly in Germany, 50 per cent of the doctors voted for ‘insurance coverage’ as the second biggest challenge in treating patients affected with COVID-19.
The report further notes that several regulatory agencies around the world such as US Food and Drug Administration (US FDA) and the European Medicines Agency (EMA) among others have been issuing new guidance to help accelerate development and approval of diagnostic tests, therapies and vaccines for COVID-19.
This guidance ranges from emergency use authorization and expedited regulatory reviews and approvals to assist with clinical trial design.
The global fight against COVID-19 has found powerful tools in the form Artificial Intelligence, Machine Learning, Big Data and IoT technologies that are playing a key role in drug discovery and development, diagnostics, disease awareness and monitoring, and patient and resource management.
These transformative technologies, both separately and in combination with each other, have enabled real-time collection and analysis and transmission of data. The data, along with the devices themselves, create the Internet of Medical Things (IoMT), which when coupled with other digital technologies, establishes a highly interconnected digital ecosystem that collects real-time data to be used by AI to comprehend healthcare trends, design innovative new drugs and predict treatment outcomes.
Ashwin Mittal, CEO of Course5 Intelligence, said the report gives an insight into the most recent medical, regulatory, and technological advances in our global response against the COVID-19 pandemic.
''The global healthcare system has shown tremendous resilience over the past few months with collaborations between pharmaceutical companies, research institutes, public health bodies and governments like never before. Our report is designed to help and to provide useful insights to all of these stakeholders in the fight against the pandemic. While the fight is far from over, our collective resolution coupled with technological advancements makes us hopeful for a brighter tomorrow.''
Course5’s COVID-19 report maps the pathology of the disease, advances in diagnostics, therapeutic interventions covering treatment and vaccines, and the role of AI and digital technologies in the fight against the pandemic. The report also compares COVID-19 with SARS and MERS and tries to draw lessons learned from past epidemics to aid policymaking during COVID-19.
More News
Mahindra Manulife Mutual Fund Launches ‘Mahindra Manulife Arbitrage Yojana,’ an open ended scheme investing in arbitrage opportunities

Mahindra Manulife Mutual Fund Launches ‘Mahindra Manulife Arbitrage Yojana,’ an open ended scheme investing in arbitrage opportunities

12 Aug 2020 | 5:20 PM

Kolkata, Aug 12 (UNI) Mahindra Manulife Mutual Fund, a wholly owned subsidiary of Mahindra and Mahindra Financial Services Limited (MMFSL) launches ‘Mahindra Manulife Arbitrage Yojana,’ an open ended scheme for investment in arbitrage opportunities available in equity, derivatives and debt markets.

see more..

Bharat Forge Q1 net loss at Rs 127 32 cr

12 Aug 2020 | 5:12 PM

Mumbai, Aug 12 (UNI) Bharat Forge has reported a net loss of Rs 127.32 crores for the quarter ended June 30, 2020 as against net profit of Rs.171.92 crores for the quarter ended June 30, 2019.

see more..

Valuefy steers against the currents to hire a new COO as part of their global expansion

12 Aug 2020 | 5:10 PM

MUMBAI, India, Aug. 12, 2020 /PRNewswire/ -- Valuefy, a premier investment technology company, soars high to hire Yateen Chodnekar as their new Chief Operating Officer for their global operations. Yateen has extensive experience over two decades in leading IT teams across multinational organizations like Boston Consulting, Merrill Lynch, Deutsche Bank, and Morgan Stanley. In his prior roles as CIO, Board Member, he has groomed multi-country, multi-cultural teams to support businesses across borders.

see more..

Unbxd announces game-changing 5-minute AI-powered search and product discovery setup tool for online retailers

12 Aug 2020 | 5:08 PM

SAN MATEO, California, Aug. 12, 2020 /PRNewswire/ -- Unbxd Inc., a leading provider of AI-based Commerce Search and Product Discovery solutions, announced its new 5-minute AI activation tool for online commerce businesses. With this new feature, online commerce sites across verticals will be able to set up sophisticated and contextually relevant search within minutes of creating an account with Unbxd using AI, dramatically increasing customer conversions and sales.

see more..
Tata Motors launches new initiative 'Sanitised by Tata Motors'

Tata Motors launches new initiative 'Sanitised by Tata Motors'

12 Aug 2020 | 5:08 PM

Mumbai, Aug 12 (UNI) Auto major, Tata Motors on Wednesday announced the launch of its new initiative 'Sanitised by Tata Motors 'to assure customers about the highest standards of safety being followed in their car dealerships, nationwide.

see more..